BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 30566178)

  • 1. Risk Factors of Subsequent Primary Melanomas in Austria.
    Müller C; Wendt J; Rauscher S; Sunder-Plassmann R; Richtig E; Fae I; Fischer G; Okamoto I
    JAMA Dermatol; 2019 Feb; 155(2):188-195. PubMed ID: 30566178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.
    Haenssle HA; Mograby N; Ngassa A; Buhl T; Emmert S; Schön MP; Rosenberger A; Bertsch HP
    JAMA Dermatol; 2016 Mar; 152(3):291-8. PubMed ID: 26536613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
    Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
    JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma.
    Vernali S; Waxweiler WT; Dillon PM; Kanetsky PA; Orlow I; Luo L; Busam KJ; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Gallagher RP; Zanetti R; Rosso S; Sacchetto L; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Thomas NE;
    JAMA Dermatol; 2017 Oct; 153(10):1026-1031. PubMed ID: 28746718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Confocal Morphologic Classification and Clinical Phenotypes of Multiple Primary and Familial Melanomas.
    Grazziotin TC; Alarcon I; Bonamigo RR; Carrera C; Potrony M; Aguilera P; Puig-Butillé JA; Brito J; Badenas C; Alós L; Malvehy J; Puig S
    JAMA Dermatol; 2016 Oct; 152(10):1099-1105. PubMed ID: 27579522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between familial and sporadic cutaneous melanoma in Valencia, Spain.
    Nagore E; Botella-Estrada R; Garcia-Casado Z; Requena C; Serra-Guillen C; Llombart B; Sanmartin O; Guillen C
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):931-6. PubMed ID: 18355200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors Associated With First and Second Primary Melanomas in a High-Incidence Population.
    Olsen CM; Pandeya N; Dusingize JC; Neale RE; MacGregor S; Law MH; Whiteman DC;
    JAMA Dermatol; 2023 Jan; 159(1):37-46. PubMed ID: 36416830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.
    van der Rhee JI; Krijnen P; Gruis NA; de Snoo FA; Vasen HFA; Putter H; Kukutsch NA; Bergman W
    J Am Acad Dermatol; 2011 Aug; 65(2):281-288. PubMed ID: 21570156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contributions by MC1R Variants to Melanoma Risk in Males and Females.
    Wendt J; Mueller C; Rauscher S; Fae I; Fischer G; Okamoto I
    JAMA Dermatol; 2018 Jul; 154(7):789-795. PubMed ID: 29898205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of patients at high risk of melanoma in Austria.
    Müller C; Wendt J; Rauscher S; Burgstaller-Muehlbacher S; Sunder-Plassmann R; Scheurecker C; Richtig E; Fae I; Fischer G; Pehamberger H; Okamoto I
    Br J Dermatol; 2016 Jun; 174(6):1308-17. PubMed ID: 26800492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Phenotypic Characteristics and UV Radiation Exposure With Risk of Melanoma on Different Body Sites.
    Ghiasvand R; Robsahm TE; Green AC; Rueegg CS; Weiderpass E; Lund E; Veierød MB
    JAMA Dermatol; 2019 Jan; 155(1):39-49. PubMed ID: 30477003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter case-control study of risk factors for cutaneous melanoma in Valencia, Spain.
    Ballester I; Oliver V; Bañuls J; Moragón M; Valcuende F; Botella-Estrada R; Nagore E
    Actas Dermosifiliogr; 2012 Nov; 103(9):790-7. PubMed ID: 22626452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations.
    Potrony M; Puig-Butille JA; Aguilera P; Badenas C; Tell-Marti G; Carrera C; Javier Del Pozo L; Conejo-Mir J; Malvehy J; Puig S
    JAMA Dermatol; 2016 Apr; 152(4):405-12. PubMed ID: 26650189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
    Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
    J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status.
    Helgadottir H; Tuominen R; Olsson H; Hansson J; Höiom V
    J Am Acad Dermatol; 2017 Nov; 77(5):893-901. PubMed ID: 28818438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total Nevi, Atypical Nevi, and Melanoma Thickness: An Analysis of 566 Patients at 2 US Centers.
    Geller AC; Mayer JE; Sober AJ; Miller DR; Argenziano G; Johnson TM; Swetter SM
    JAMA Dermatol; 2016 Apr; 152(4):413-8. PubMed ID: 26934430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nevi, family history, and fair skin increase the risk of second primary melanoma.
    Siskind V; Hughes MC; Palmer JM; Symmons JM; Aitken JF; Martin NG; Hayward NK; Whiteman DC
    J Invest Dermatol; 2011 Feb; 131(2):461-7. PubMed ID: 20944647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoor tanning exposure in association with multiple primary melanoma.
    Karapetyan L; Yang X; Wang H; Sander CA; Moyer A; Wilson M; Karunamurthy A; Kirkwood JM
    Cancer; 2021 Feb; 127(4):560-568. PubMed ID: 33170961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of TERT promoter mutations in differentiating recurrent nevi from recurrent melanomas: A retrospective, case-control study.
    Walton KE; Garfield EM; Zhang B; Quan VL; Shi K; Mohan LS; Haugh AM; VandenBoom T; Yazdan P; Isales MC; Panah E; Gerami P
    J Am Acad Dermatol; 2019 Mar; 80(3):685-693. PubMed ID: 30287318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families.
    van der Rhee JI; de Snoo FA; Vasen HFA; Mooi WJ; Putter H; Gruis NA; Kukutsch NA; Bergman W
    J Am Acad Dermatol; 2011 Aug; 65(2):289-296. PubMed ID: 21570154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.